Biosimilar medicines: the intersection of access, affordability, and innovation
3 February 2025
Director of Biosimilar Policy & Science at Medicines for Europe, Julie Maréchal-Jamil, discusses the necessary strategies at both European and national levels to ensure the continued advantages of biosimilar medicines.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
